<DOC>
	<DOC>NCT01476904</DOC>
	<brief_summary>E004-C2 is a continuation of E004-C for safety evaluations with additional 3 months to be able to assess the 6-month safety profile for E004 (epinephrine inhalation) versus placebo in a double-blinded manner.</brief_summary>
	<brief_title>Safety Study in Adolescent and Adult Patients With Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Epinephrine</mesh_term>
	<mesh_term>Racepinephrine</mesh_term>
	<mesh_term>Epinephryl borate</mesh_term>
	<criteria>Only subjects who have successfully completed the E004C study within the last 135 days or those who are actively enrolled in the current study E004C at the time of the study extension initiation Male and female asthma patients aged 12 75 years Patients with documented asthma, requiring inhaled epinephrine or beta 2agonist treatment No significant changes in asthma therapy and no asthmarelated hospitalization or emergency visits, within 4 weeks prior to Screening Demonstrating satisfactory techniques in the use of metereddose inhaler and a hand held peak expiratory flow meter Female patients of childbearing potential must be nonpregnant and nonlactating at Screening and throughout the study, and must use an acceptable method of contraception during the study A smoking history of 10pack years, or having smoked within 12 months of screening Any current or past medical conditions that, per investigator discretion, might significantly affect responses to the study drugs, other than asthma Concurrent clinically significant diseases Known intolerance or hypersensitivity to any component of the study drugs Recent infection of the respiratory tract, before screening Use of prohibited medications Having been on other investigational drug/device studies in the last 30 days prior to screening Known or highly suspected substance abuse</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Bronchial Asthma</keyword>
	<keyword>Shortness of breath</keyword>
</DOC>